Groundbreaking ARUP Research Clarifies Clinical Value of Atypical Cell-Free DNA Screening Results
<p>SALT LAKE CITY, Sept. 8, 2026 /PRNewswire/ -- An extensive, first-of-its-kind research study by ARUP Laboratories clarifies the clinical value of atypical findings from prenatal cell-free DNA (cfDNA) screening and their impact on pregnancy outcomes. The study, which investigated the...</p>
Read original article ↗